<DOC>
	<DOC>NCT01016210</DOC>
	<brief_summary>To explore whether recombinant LH (rLH) supplementation (Leuveris) to recombinant follicle stimulating hormone (rFSH) following GnRH antagonist treatment has an advantage in infertile women with advanced reproductive ageing undergoing IVF-ET.</brief_summary>
	<brief_title>The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)</brief_title>
	<detailed_description />
	<criteria>female candidate to IVF between 3045 years old not included for fertilization</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>pregnancy</keyword>
	<keyword>IVF</keyword>
</DOC>